Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917).
Takahiro NakayamaTetsuhiro YoshinamiHiroyuki YasojimaNobuyoshi KittakaMasato TakahashiShoichiro OhtaniSeung Jin KimHiroyuki KurakamiNaoko YamamotoTomomi YamadaTakehiko TakataNorikazu MasudaPublished in: BMC cancer (2021)
UMIN000038296 ; registered on 15 October 2019.